baber/WOPTO huggingface dataset:
Patent NZ-547564-A (NZ)
Title: Plasmid maintenance
Inventor: CRANENBURGH ROCKY MARC
IPC: C12N15/64
Filed: 2004-11-22
Abstract: Provided is a transformed prokaryotic host cell comprising i) a chromosomal gene which inhibits cell growth, operably linked to a regulatory sequence encoding RNAII or a portion thereof; and ii) a plasmid comprising an origin of replication encoding an antisense sequence which is RNAI or portion thereof, wherein the binding of the antisense sequence encoded by RNAI to mRNA transcribed from RNAII inhibits the action of the chromosomal gene, thereby permitting cell growth. Further provided are similar prokaryotic host cells wherein the plasmid encodes an antisense sequence which is RNAI binding to mRNA transcribed from RNAI. Further provided are methods of maintaining the plasmid in a host cell, producing the plasmid, producing a recombinant protein using the host cells, pharmaceutical compositions comprising the host cells and use of the host cells in the manufacture of medicaments.
Patent NZ-548999-A (NZ)
Title: A culture medium for the production of filamentary fungi
Inventor: PANCHAUD-MIRABEL ELISABETH
IPC: C12N1/14
Filed: 2005-02-08
Abstract: Disclosed is a culture medium for filamentary fungi comprising 60-65% molasses, 10-15% sucrose, 10-15% corn steep liquor and 10-15% yeast extract.
Patent NZ-551392-A (NZ)
Title: Device, system and method for delivering a curable material into bone
Inventor: KRUEGER JOHN A
Filed: 2006-11-17
Abstract: A curable material delivery cannula device is disclosed. The device includes a cannula and a hub. The cannula includes an open proximal end, a deflectable segment forming a pre-set curve, a lumen, and side orifice(s) adjacent, and proximally spaced from, the distal end and fluidly connected to the lumen. When inserted within a guide cannula, the deflectable segment straightens. When distally extended from the guide cannula, the deflectable segment reverts to the curved shape. The distal end has a blunt tip for non-traumatic interface with bodily material. During use, curable material, such as bone cement, is delivered from the side orifice(s) in a radial direction relative to the lumen.
Patent NZ-554683-A (NZ)
Title: System and method of monitoring multiple ovens
Inventor: WILLETT PAUL EATON
Filed: 2007-04-23
Abstract: Methods and systems for operating multiple ovens (12-18) are disclosed. Information is received on the current conditions in, and usage of, each oven. An operator inputs a required condition to be met by one of the ovens to satisfy particular requirements for a new bake job and base on the received information, an indication is provided of which of the ovens currently meets the condition or will meet the condition in the shortest time.
Patent NZ-579312-A (NZ)
Title: Circular buffer based rate matching
Inventor: MALLADI DURGA PRASAD
IPC: H04L1/00
Filed: 2008-03-27
Abstract: A method that facilitates rate matching in a wireless communication environment and an apparatus in a wireless communication system are disclosed. The method is implemented by at least one apparatus and comprises separating systematic bits, parity 1 bits, and parity 2 bits from an encoder into distinct groups; interleaving the systematic bits, the parity 1 bits, and the parity 2 bits within the respective, distinct groups; interlacing the interleaved parity 1 bits with the interleaved parity 2 bits; inserting the interleaved systematic bits into a circular buffer followed by the interlaced and interleaved parity 1 and parity 2 bits; and sequentially selecting the bits inserted into the circular buffer, starting at a selected location of the circular buffer, for transmission. The method further comprises interleaving the systematic bits together to randomize an ordering of the systematic bits; interleaving the parity 1 bits together to randomize an ordering of the parity 1 bits; and interleaving the parity 2 bits together to randomize an ordering of the parity 2 bits. Also disclosed is a wireless communications apparatus that enables employing rate matching in a wireless communication environment, comprising means for interleaving systematic bits collected from at least one encoded block outputted by an encoder (814); means for interleaving parity 1 bits collected from the at least one encoded block (814); means for interleaving parity 2 bits collected from the at least one encoded block (814); means for interlacing the interleaved parity 1 bits and the interleaved parity 2 bits; means for inserting the interleaved systematic bits into a circular buffer followed by the interlaced and interleaved parity 1 and parity 2 bits (820); and means for sequentially selecting the bits inserted into the circular buffer, starting at a selected location of the circular buffer, for transmission (822).
Patent NZ-580034-A (NZ)
Title: Messaging an established relationship between a monitored activity and a further behaviour/environment parameter
Inventor: GIBSON DAVID JOHN MICHAEL
IPC: A01K29/00
Filed: 2010-12-24
Abstract: Disclosed is an animal messaging system. The system is comprised of an animal monitoring means (105), at least one source of additional information (145) and a processor (130). The animal monitoring means (105) provides data on the activities of an animal. The at least one source of additional information (145) provides information relating to the animal's behaviour and/or environment. The processor (130) identifies an activity from the data provided by the animal monitoring means (105) and establishes a relationship between the activity and the additional information. The processor (130) then generates a message expressing the identified activity and the established relationship.
Patent NZ-584369-A (NZ)
Title: Method for clinical staging of interstitial pneumonia using PGE-MUM and reagent kit thereof
Inventor: FUJIWARA MUTSUNORI
IPC: G01N33/493
Filed: 2006-04-14
Abstract: Disclosed is a method for judging stages between an active phase and a non-active phase of interstitial pneumonitis comprising the steps of: Setting as a base value a value of PGE-MUM concentration in urine obtained by measuring PGE-MUM contained in urine of patients diagnosed as being in a non-active phase of interstitial pneumonitis said non-active phase having been induced by administration of anti-inflammatory drugs; and judging that the interstitial pneumonitis is in the active phase when the value of PGE-MUM concentration in urine of the patients is in a range exceeding the base value, and that the interstitial pneumonitis is in the non-active phase when the value of PGE-MUM concentration in urine of the patients is in a range of not more than the base value. (62) Divided Out of 562455
Patent NZ-587056-A (NZ)
Title: Method for modulating calcium ion-release-activated calcium ion channels
Inventor: XIE YU
IPC: A61K31/415
Filed: 2004-07-22
Abstract: Disclosed is the use of a substituted biphenyl compound of formula (VII) where the substituent is as disclosed in the specification, in the manufacture of a medicament for immunosuppression, treating or preventing inflammatory condition, immune disorder or allergic disorder. Also disclosed is a method of inhibiting a Ca2+-release-activated Ca2+ ion channel in a cell in vitro or in a non-human mammal for immunosuppression or for treating or preventing an inflammatory condition, immune disorder or allergic disorder, comprising administering a compound of formula (VII). Examples of compound of formula (VII) are: 3-Fluoro-N-(3'-trifluoromethyl- biphenyl-4-yl)-isonicotinamide; N-(2,2'-Bis-trifluoromethyl- biphenyl-4-yl)-2,3-difluoro-benzamide and 4-Trifluoromethyl-N- (2' -trifluoromethyl-biphenyl-4-yl)-nicotinamide.
Patent NZ-590641-A (NZ)
Title: System for treating obstructive sleep apnea comprising an auxiliary airway to bypass a oropharynx region of the pharynx
Inventor: ROUSSEAU ROBERT A
IPC: A61F2/20
Filed: 2009-07-29
Abstract: 590641 A system for treating obstructive sleep apnea (OSA) comprising an elongated conduit (50) adapted to be implanted beneath a pharyngeal wall of a pharynx. The elongated conduit having a proximal end a distal end adapted to be in communication with the pharynx bypassing an oropharynx. The elongated conduit includes a central lumen (52) extending between the proximal and distal ends and a flexible mandrel (56) insertable within the central lumen for supporting the elongated conduit as it is implanted. The flexible mandrel (56) has a length greater than or equal to the length of the conduit (50).
Patent NZ-591205-A (NZ)
Title: Pharmaceutical compositions comprising clevidipine and methods for producing low impurity concentrations of the same
Inventor: MOTHERAM RAJESHWAR
IPC: A01N43/90
Filed: 2009-07-29
Abstract: Disclosed is a pharmaceutical composition comprising an oil-in-water emulsion of clevidipine (as pictured) or any of its pharmaceutically acceptable salts as an active ingredient, and a degradant H168/79 wherein the amount of degradant is approximately equal to or less than about 1.5 per cent on a weight by weight basis. Also disclosed is a method of reducing impurities in a composition comprising clevidipine, comprising: heating an oil to between to about 70 degrees C to about 82 degrees C; adding to the heated oil clevidipine and heating the mixture to about 78 degrees Celsius to about 82 degrees Celsius; adding to the mixture egg yolk phospholipids; and adding an aqueous phase; wherein the pH is adjusted to about 6 to about 8.8; homogenizing the emulsion. Further disclosed is the use of the composition for the manufacture of a medicament for treating or preventing hypertension in a patient.
Patent NZ-592944-A (NZ)
Title: Drink valve with a plunger and spring
Inventor: NOORDANUS MAXIMILIAAN
IPC: B67D3/04
Filed: 2006-11-16
Abstract: Draw-off valve for a drinks reservoir 40, comprises a tubular body comprising therein a channel 6 extending from an inlet 4 to an outlet 5, a plunger 7 and a spring 10. The plunger 7 comprises a stem 8 and a head 9, the head 9 oriented toward the inlet 4 and the stem 8 extending from the head 9, through the channel 6, in the direction of the outlet 5 .When viewed in the direction of passage, the channel 6 narrows, narrowing from a first internal cross section Dl) to a second internal cross section D2, the internal narrowing forming a seat 12 for the underside, facing the outlet 5, of the head 9. The plunger 7 is movable back and forth between a closed position where the underside of the head 9 rests on the seat 12 and an opened position where the underside of the head 9 is located at a distance above the seat 12. The spring 10 acts on the one hand, on the tubular body and, on the other hand, on the plunger 7 in order to bias the plunger 7 into the closed position. The seat 12 and the underside of the head 9 are formed in such a way that, when positioned against each other under the influence of the biasing spring 10, they form a sealing closure of the channel 6. The stem 8 of the plunger 7 carries at the downstream end of the stem 8, a tube part which interlocks non-displaceably with a downstream portion of the tubular body. The tubular body comprises a tube zone between the seat 12, in particular the external narrowing, and the site of interlocking of the tube part with the tubular body. The tube zone wall is formed in such a way that the wall allows an axial shortening of the tube zone when the axial distance between the seat 12 and the site of interlocking of the tube part with the tubular body decreases.
Patent NZ-596810-A (NZ)
Title: Imidazole derivatives as mglur5 antagonists
Inventor: VIEIRA ERIC
IPC: C07D403/04
Filed: 2010-07-14
Abstract: 596810 Disclosed herein is a compound of general formula I, wherein the variables are defined in the specification. It has been found that the compounds of general formula (I) are metabotropic glutamate receptor antagonists. They can be used in the treatment or prevention of mGluR5 receptor mediated disorders, such as Alzheimer’s disease. In one embodiment the compound is 6-(2,5-dimethyl-4-m-tolylethynyl-imidazol-1-yl)-3-methyl-3H-pyrimidin-4-one.
Patent NZ-599054-A (NZ)
Title: Diagnosis of collagen IX destruction
Inventor: HEINEGARD DICK
IPC: G01N33/68
Filed: 2008-02-29
Abstract: Disclosed is a method of detecting or monitoring a human disorder affecting connective tissues, comprising determining the levels of cleaved protein fragments of the alpha-1 chain of collagen IX in a blood sample or a synovial fluid sample, wherein the fragments are selected from the group created by a cleavage at a site between glycine-400 and threonine-401 in the RGPPGPPGPPGPRG400TIGFHDGD408 of the human collagen IX alpha 1 chain in the COL3 domain. Further disclosed is a cleavage neoepitope in the COL3 domain, an antibody having specific reactivity with said cleavage neoepitope, and a diagnostic kit adapted for detecting or monitoring a human disorder affecting connective tissues comprising said antibody. Also disclosed is a method of locating collagen cleavage in a tissue sample, comprising detecting said neoepitope.
Patent NZ-599590-A (NZ)
Title: Factor involved in latent infection with herpesvirus, and use thereof
Inventor: KONDO KAZUHIRO
IPC: C07K14/03
Filed: 2012-04-24
Abstract: 599590 Discloses a gene encoding a protein as shown in SEQ ID NO: 1 (Human herpesvirus 6B), a gene encoding a protein having an amino acid sequence with 5 or less amino acid changes in the sequence as shown in SEQ ID NO: 1, a gene comprising the nucleotide sequence of SEQ ID NO: 2. An antibody which binds to the protein of SEQ ID NO: 2, a recombinant expression vector and a gene detection instrument comprising a probe for SEQ ID NO: 1 or 2.
Patent NZ-602068-A (NZ)
Title: Compositions and methods for increasing biomass, iron concentration, and tolerance to pathogens in plants
Inventor: LAKSHMANAN VENKATACHALAM
IPC: C12N15/01
Filed: 2011-03-01
Abstract: Discloses a method for enhancing a characteristic of a plant, the method comprising administering a composition comprising Bacillus subtilis FB17 to a seed to produce an enhanced characteristic in the plant grown from the seed, wherein the enhanced characteristic is a decreased lignin content or increased iron concentration. Further discloses a method of coating a plant seed with Bacillus subtilis FB17, the plant seed coating with Bacillus subtilis FB17 and the plant seed comprising a coating of Bacillus subtilis.
Patent NZ-608005-A (NZ)
Title: Search and rescue using ultraviolet radiation
Inventor: WITZEL JOHN GEORGE
IPC: G01S17/02
Filed: 2011-09-23
Abstract: A system includes an ultraviolet c-band radiation detector (130) to enable detection of radiation (112) during search and rescue operations and a stimulus generator. At least a portion of the radiation detected includes ultraviolet c-band radiation. The stimulus generator is configured to generate a stimulus in response to the detected ultraviolet c-band radiation. The ultraviolet c-band radiation detector comprises a first and a second detector, to enhance system sensitivity and facilitate detection of relatively weak radiation sources, relatively distant sources, and/or radiation scattered about an environment. Further included is a circuit for synchronizing the signal from at least the first and second detectors.
Patent NZ-611800-A (NZ)
Title: Lattice cutting machine
Inventor: WALKER DAVID B
IPC: B26D5/14
Filed: 2012-01-03
Abstract: A lattice cutting or slicing machine is disclosed. The machine includes a multi-knife lattice cutting plate (14) mounted in-line along a hydraulic flow path through which vegetable products such as potatoes are propelled in single file by a hydraulic fluid such as water. The lattice cutting plate is orbitally driven for engaging in succession each of the multiple knives thereon with the vegetable product to form lattice cut slices. These are formed by successive generally corrugated cuts that are angularly oriented perpendicular to each other and where the depths or troughs of the corrugated cuts on opposite sides of each slice intersect in the preferred form to define a pattern of corrugations interrupted by small openings.
Patent NZ-613856-A (NZ)
Title: Topical antifungal agent
Inventor: TABATA YUJI
IPC: C07D231/22
Filed: 2012-01-30
Abstract: Disclosed are compounds having a 2-(1H-pyrazol-1-yl)phenol backbone represented by formula (I), where the substituents are defined herein, an example being 2-(3,5-dimethyl-1H-pyrazol-1-yl)-4-fluorophenol or 2-(3,4,5-trimethyl-1H-pyrazol-1-yl)phenol. The compounds are intended for use as topical anti-fungal agents, particularly for the treatment of tinea, or tinea unguium.
Patent NZ-617726-A (NZ)
Title: Coating compositions comprising 2,2’-biphenol
Inventor: KALEEM KAREEM
IPC: C09D163/02
Filed: 2012-05-01
Abstract: Disclosed herein is the use of a coating compositions comprising a polyglycidyl ether of a 2,2’-biphenol, wherein said coating is substantially free of bisphenol A and/or derivatives and/or residues thereof and bisphenol F and/or derivatives and/or residues thereof for coating food and/or beverage packaging. Also disclosed are methods of coating substrates using the coating compositions and substrates such as metal cans coated with the coating compositions.
Patent NZ-622928-A (NZ)
Title: Crystal of 5-hydroxy-1h-imidazole-4-carboxamide·3/4 hydrate, method for producing the same and crystal of 5-hydroxy-1 h-imidazole-4-carboxamide hydrate
Inventor: FUJIMOTO TAISUKE
IPC: C07D233/90
Filed: 2012-09-28
Abstract: Disclosed is a method for producing 5-hydroxy-1H-imidazole-4-carboxamide 3/4 hydrate, which comprises: a step wherein 2-amino malonamide is reacted with trimethyl orthoformate in the presence of a carboxylic acid (formic acid or oxalic acid) so as to obtain 5-hydroxy-1H-imidazole-4-carboxamide; a step wherein the thus-obtained 5-hydroxy-1H-imidazole-4-carboxamide is reacted with an acidic compound so as to obtain an acidic salt of 5-hydroxy-1H-imidazole-4-carboxamide or a hydrate thereof; and a step wherein the thus-obtained acidic salt of 5-hydroxy-1H-imidazole-4-carboxamide or a hydrate thereof is reacted with a salt in the presence of an acidic solvent.
Patent NZ-623376-A (NZ)
Title: Method for measuring the position of a surface of a vehicle
Inventor: NAGY OLIVER
IPC: G07B15/06
Filed: 2014-04-03
Abstract: A method for measuring the position of a surface of a vehicle on a roadway is disclosed. The method comprises transmitting two or more radar beams with different directions from same transmitting position downwardly at an angle, then receiving reflected radar beams corresponding to the transmitted radar beams at the same receiving position. The transmitting position and the receiving position are distanced from one another, and the transmitting directions and receiving directions for corresponding radar beams lie in a common plane. Then, select the received signal having the greatest signal strength; and determining the position of a surface of a vehicle from the transmitting and receiving positions and from the transmitting and receiving directions.
Patent NZ-625564-A (NZ)
Title: Embryo insertion system and method
Inventor: TEODORO MICHAEL W
IPC: A01C1/06
Filed: 2012-12-13
Abstract: The present disclosure is directed generally towards to embryo insertion systems and methods for use with manufactured seeds. In some embodiments, embryo insertion systems according to the disclosure include an embryo delivery assembly and a fill material deposit assembly. The embryo delivery assembly may include an insertion member, a release assistance member, and a fill material deposit assembly. The fill material deposit assembly may include a fill material containment device, a fill material conveyance device, and optionally, a fill material separation device. Further aspects of the disclosure relate to methods for operating embryo insertion systems according to embodiments of the disclosure to enable simultaneous embryo insertion and fill material delivery.
Patent NZ-630451-A (NZ)
Title: Substance delivery apparatus, substance delivery system and method of substance delivery
Inventor: EDWARDS DAVID ROYCE
IPC: A61M37/00
Filed: 2014-01-10
Abstract: A drench gun (10) for discharging a dose of a fluid substance or medicament to an animal is described. The gun is hand held and driven by a portable pressurised gas canister or vessel (65). It includes a sensor for measuring the amount of drench (34) and a control valve (67) for controlling the amount distributed. The device optionally includes an identification device (84) that can read an RFID or other antenna attach to the animal to decide how much medicament is to be delivered, based on weight or age.
Patent NZ-702413-A (NZ)
Title: Compound as wnt signaling inhibitor, composition, and use thereof
Inventor: AN SONGZHU
IPC: C07D471/04
Filed: 2012-06-15
Abstract: The present invention relates to a compound having the structure of Formula I as inhibitor of WNT signal transduction pathways, as well as a composition comprising the compound. Further, the present invention relates to the use of the compound and the method of inhibiting the WNT signal transduction pathways.
Patent NZ-705761-A (NZ)
Title: Flexible tubing with embedded helical conductors and method of making
Inventor: CARLSON ERIC
IPC: H05B3/02
Filed: 2011-09-24
Abstract: Disclosed is a thin walled, flexible and collapse-resistant thermoplastic tubing (410) having a substantially smooth bore and a method for making the tubing is disclosed. The tubing (410) includes at least one conductor (416) helically disposed within the support bead structure. The tubing comprises: a flexible tubing wall formed of a thermoplastic ribbon (422), a plateau portion (412b) on the flexible tubing wall, at least one elongate conductor (416), and an elongate thermoplastic support bead (414). The ribbon (422), while molten, is helically wrapped repeatedly on itself to overlap a certain amount forming a helical lap joint where successive wraps of the ribbon (422) heat-bond integrally to one another so that an elongate tubular body is formed. The plateau portion (412b) on the flexible tubing wall defines at least one elongate groove (428a) where the elongate groove (428a) converges in a radially outward direction to open radially on the plateau portion (412b). The elongate conductor (416) is disposed in one or more grooves (428a) and helically around and along the elongate tubular body. The elongate thermoplastic support bead (414) is disposed helically around and along the elongate tubular body on the plateau portion (412b) so the support bead (414) and the plateau portion (412b) cooperatively form the bead structure.
Patent NZ-708756-A (NZ)
Title: Therapeutic agent for keratoconjunctive disorders
Inventor: KIMURA KAZUHIRO
IPC: A61P27/14
Filed: 2013-11-07
Abstract: The present invention addresses the problem of providing a novel therapeutic agent for keratoconjunctive disorders. As a means for solving the problem, a therapeutic agent for keratoconjunctive disorders which contains a RARγ agonist as an active ingredient is provided. The therapeutic agent exhibits an excellent ameliorating effect in a keratoconjunctive disorder model, and is therefore useful as a therapeutic agent for keratoconjunctive disorders such as corneal ulcer, corneal epithelial abrasion, keratitis, dry eye, conjunctivitis, chronic superficial keratitis, corneal erosion, persistent corneal disorders, superficial punctate keratopathy, corneal epithelial defects, conjunctival epithelial defects, keratoconjunctivitis sicca, superior limbic keratoconjunctivitis, filamentary keratoconjunctivitis, infectious keratitis, noninfectious keratitis, infectious conjunctivitis and noninfectious conjunctivitis. The therapeutic agent is also useful as a therapeutic agent for corneal scarring and conjunctival scarring both associated with keratoconjunctive disorders.
Patent NZ-712989-A (NZ)
Title: Low extract component, beer-taste beverage having adjusted ph
Inventor: TERANISHI TAKESHI
IPC: A23L2/38
Filed: 2012-11-19
Abstract: Discloses a non-alcohol, beer-taste beverage whose total amount of an extract component(s) is 0.5% by weight or higher and 2.0% by weight or lower, having a pH of3.5 or higher and 4.5 or lower.